Yesterday, Sunday, in Algiers, the Algerian bioequivalence center “Equival Biocenter” presented its first bioequivalence study to demonstrate the therapeutic efficacy of a generic antibiotic produced by the state-owned pharmaceutical group “Saidal”. Read more…
Towards pharmaceutical self-sufficiency
Algeria has taken a crucial step in its strategy of pharmaceutical self-sufficiency, with the official inauguration of the second private bioequivalence center launched by Clinica Group. Read more…
October 30, 2024
